IndraLab

Statements

Ibrutinib inhibits NFKB1. 2 / 2

| 2

➶

reach

"As B-cell receptor (BCR) modulator, ibrutinib indirectly inhibits the classical NF-KB pathway."

27449094

➶

reach

"In addition, pathways identified in this study such as PI3K-AKT-mTOR signaling inhibited using the drugs idelalisib, AZD8835, and rapamycin; BCR and NF-KB signaling inhibited by ibrutinib and bortezomib can be combined with R-CHOP."

36831263

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ibrutinib inhibits NFKB1. 2 / 2

INDRA sources:

Databases

Reading